Little information was given regarding the nature of controls and the timing of sampling, and the study analyzed a non-homogeneous cohort of GBM (naïve and recurrent), IDH-mutated and -wt, and other neuronal/glial malignancies. This evidence concerns the gene IDH2 and glioblastoma.